| Date | Form | Description | Docs | XBRL | Pages |
| 01/31/11 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
4 | |
| 06/29/10 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
81 | |
| 03/10/10 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
80 | |
| 01/29/10 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
121 | |
| 01/16/09 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
59 | |
| 01/15/09 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 01/15/08 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
57 | |
| 01/15/08 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 01/25/07 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
10 | |
| 01/16/07 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
60 |
Latest News & Events
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference
Read More...Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium
Read More...Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Read More...